COL1A1 rs1800058: Bone Mineral Density and Fracture Risk
The rs1800058 variant is a single nucleotide polymorphism located within the COL1A1 gene, which provides instructions for making part of type I collagen. Research has investigated its association with variations in bone mineral density and the risk of bone fractures across various populations.
What each genotype means
Typical bone density profile
This genotype represents the most common form of this variant in the general population. Research into this specific site in the COL1A1 gene has explored its potential role in bone mineral density, though findings regarding its impact on fracture risk remain mixed and modest across different studies.
This is the most common genotype observed in global populations.
Varied bone density association
Individuals with this genotype carry one copy of the minor allele. While some studies have investigated this variant as a candidate for bone mineral density and fracture risk, the evidence is considered moderate and inconsistent, meaning it is not a strong predictor of bone health on its own.
This genotype is relatively uncommon, appearing in a small percentage of the population.
Minor allele bone association
This genotype represents the homozygous minor state for this variant. While COL1A1 is a critical gene for bone structure, the specific association of this variant with clinical bone outcomes is modest and should be interpreted as only one of many complex genetic and environmental factors influencing bone health.
This is the least common genotype, found in a very small fraction of the population.
Understanding the rs1800058 Variant
The rs1800058 variant is a specific change in the DNA sequence located in the regulatory region of the COL1A1 gene. In genetics, a single nucleotide polymorphism, or SNP, represents a variation at a single position in the DNA chain. This particular variant involves a substitution where one nucleotide is replaced by another. Because this SNP is situated in a region that influences how the gene is turned on or off, researchers have long hypothesized that it could alter the expression levels of the collagen protein. By studying this site, scientists aim to understand how subtle genetic differences contribute to the structural integrity of human tissues. It is important to note that while this variant is well-documented in genetic databases, it is just one of many thousands of variations that contribute to the complex architecture of human bone health and skeletal development.
The Role of the COL1A1 Gene
The COL1A1 gene encodes the pro-alpha1 chain of type I collagen, which is the most abundant protein in the human body. Type I collagen is a critical structural component of the extracellular matrix, providing tensile strength and flexibility to bones, skin, tendons, and ligaments. Within the bone, collagen fibers form a scaffold upon which minerals like calcium and phosphate are deposited to create hard, dense tissue. When the COL1A1 gene functions optimally, it ensures the production of high-quality collagen fibers necessary for maintaining skeletal strength. Mutations in this gene can lead to conditions like osteogenesis imperfecta, a disorder characterized by fragile bones. However, common variants like rs1800058 are generally considered to have much more subtle effects on collagen production compared to the rare, high-impact mutations that cause severe genetic diseases. Understanding this gene is essential for grasping how our bodies build and maintain the skeletal system throughout our lives.
Research on Bone Density and Fracture Risk
Scientific studies have explored the link between rs1800058 and bone mineral density, a key indicator of bone strength. The evidence for this association is considered moderate, as findings have been inconsistent across different studies and ethnic groups. Some research has suggested that individuals carrying specific alleles of this variant might have a slightly higher risk of low bone mineral density or an increased susceptibility to fractures. However, other large-scale meta-analyses have found that the effect size of this SNP is relatively small, meaning it is unlikely to be a primary driver of bone health on its own. Bone density is a polygenic trait, influenced by the combined effects of hundreds of genetic variants, as well as significant environmental factors such as diet, physical activity, and hormonal status. Consequently, while rs1800058 is a recognized marker in the GWAS Catalog, it should be viewed as one small piece of a much larger, complex biological puzzle.
Interpreting Your Genetic Information
If you have received results regarding your rs1800058 genotype, it is important to maintain a balanced perspective. This variant is common, and the vast majority of people carry it without experiencing significant health issues. Genetic testing for this SNP is not a diagnostic tool for osteoporosis or fracture risk. Because the association between this variant and bone health is influenced by many other factors, your genotype alone cannot predict your future bone health. You cannot change your genetic code, but you can influence your bone health through lifestyle choices such as weight-bearing exercise, adequate calcium and vitamin D intake, and avoiding smoking. If you are concerned about your bone density or fracture risk, the most effective step is to consult with a healthcare professional. They can evaluate your overall health, family history, and clinical risk factors to provide personalized guidance or recommend a bone density scan if appropriate.
How common is this variant?
The rs1800058 variant is common across global populations, with allele frequencies varying significantly depending on ancestral background.
Frequently asked questions
Is rs1800058 a cause of osteoporosis?
No, rs1800058 is not a direct cause of osteoporosis. It is a common genetic variant that has been statistically associated with minor differences in bone mineral density, but it does not determine whether an individual will develop the condition.
Should I be worried if I have the TT genotype?
There is no reason for alarm if you carry the TT genotype. This variant is common, and its impact on bone health is considered small and highly dependent on other genetic and environmental factors.
Can a DNA test tell me if I will break a bone?
No, a DNA test cannot predict if you will break a bone. Fracture risk is determined by a combination of genetics, lifestyle, age, and physical health, which a single SNP cannot capture.
What should I do if I am concerned about my bone health?
If you are concerned about your bone health, you should speak with your primary care physician. They can assess your clinical risk factors and determine if a bone density test or other interventions are necessary.
Sources & further reading
Educational information only, last refreshed 9/30/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800058?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in COL1A1
This SNP is linked to an age-protective methylation marker in collagen genes, influencing perceived facial aging.
The Sp1 binding site polymorphism in COL1A1 has been extensively studied for associations with bone mineral density (BMD) and fracture risk, though results remain inconsistent across different populations.
An intronic Sp1 transcription factor binding-site variant (often termed the +1245 G/T or Sp1 polymorphism) that influences type I collagen alpha-1 chain synthesis, impacting tendon elasticity, cruciate ligament tear risk, and bone mineral density under mechanical loading.
Regulates Sp1 binding affinity within the COL1A1 regulatory promoter, modulating baseline bone mineral density and connective tissue flexibility traits.
A promoter polymorphism (-1997G/T) in type I collagen alpha 1 that regulates transcriptional activity and alters susceptibility to anterior cruciate ligament ruptures and tendon pathology.
Intronic collagen type I alpha 1 variant associated with cruciate ligament rupture risk and tendon tensile stiffness in sports performance.